President Trump has sworn in ex-pharma industry executive Alex Azar as his new Health Secretary – and says tackling drug prices and the opioid crisis will be among his top priorities.
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS